Ovary Syndrome for Efficient Diagnosis and Targeted Therapy - Trial NCT06102629
Access comprehensive clinical trial information for NCT06102629 through Pure Global AI's free database. This phase not specified trial is sponsored by Asian Institute of Gastroenterology, India and is currently Not yet recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Asian Institute of Gastroenterology, India
Timeline & Enrollment
N/A
Nov 05, 2023
Nov 15, 2026
Primary Outcome
Evaluate the Analysis of DNA methyl transferases,Evaluate the Analysis of differential mRNA and protein expression of epigenetic markers in ovarian tissues
Summary
OBJECTIVES:
 
 1. Analysis of DNA methyl transferases (DNMT1, DNMT3A and DNMT3B) and Histone deacetylases
 (HDAC 1,2,3 and SIRTs) polymorphisms (Somatic and germ line variations).
 
 2. Analysis of differential mRNA and protein expression of epigenetic markers in ovarian
 tissues obtained from PCOS patients.
 
 3. miRNA regulated epigenetic mechanisms in PCOS
 
 4. Epigenetic regulation of endocrine genes in PCOS
 
 DESIGN : A Case Control study.Sample size:200
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06102629
Non-Device Trial